Cargando…
Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits
BACKGROUND: In celiac disease gluten, the disease-inducing toxic component in wheat, induces the secretion of autoantibodies which are targeted against transglutaminase 2 (TG2). These autoantibodies are produced in the small-intestinal mucosa, where they can be found deposited extracellularly below...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275217/ https://www.ncbi.nlm.nih.gov/pubmed/18312620 http://dx.doi.org/10.1186/1471-2172-9-6 |
_version_ | 1782151833965297664 |
---|---|
author | Stenman, Satumarja M Lindfors, Katri Korponay-Szabo, Ilma R Lohi, Olli Saavalainen, Päivi Partanen, Jukka Haimila, Katri Wieser, Herbert Mäki, Markku Kaukinen, Katri |
author_facet | Stenman, Satumarja M Lindfors, Katri Korponay-Szabo, Ilma R Lohi, Olli Saavalainen, Päivi Partanen, Jukka Haimila, Katri Wieser, Herbert Mäki, Markku Kaukinen, Katri |
author_sort | Stenman, Satumarja M |
collection | PubMed |
description | BACKGROUND: In celiac disease gluten, the disease-inducing toxic component in wheat, induces the secretion of autoantibodies which are targeted against transglutaminase 2 (TG2). These autoantibodies are produced in the small-intestinal mucosa, where they can be found deposited extracellularly below the epithelial basement membrane and around mucosal blood vessels. In addition, during gluten consumption these autoantibodies can also be detected in patients' serum but disappear from the circulation on a gluten-free diet. Interestingly, after adoption of a gluten-free diet the serum autoantibodies disappear from the circulation more rapidly than the small-intestinal mucosal autoantibody deposits. The toxicity of gluten and the secretion of the disease-specific autoantibodies have been widely studied in organ culture of small-intestinal biopsy samples, but results hitherto have been contradictory. Since the mucosal autoantibodies disappear slowly after a gluten-free diet, our aim was to establish whether autoantibody secretion to organ culture supernatants in treated celiac disease patient biopsies is related to the duration of the diet and further to the pre-existence of mucosal TG2-specific IgA deposits in the cultured biopsy samples. RESULTS: In the organ culture system conducted with biopsies derived from treated celiac disease patients, gliadin induced secretion of autoantibodies to culture supernatants, reduced epithelial cell height and increased the density of lamina proprial CD25+ cells. However, these changes could be demonstrated only in biopsies from short-term treated celiac disease patients, where the small-intestinal mucosal TG2-specific IgA autoantibody deposits were still present. Furthermore, in these biopsies autoantibody secretion could be stimulated fully only after a 48-hour gliadin challenge. CONCLUSION: Our results show that studies focusing on the toxic effects of gliadin in the organ culture system should be carried out with biopsy samples from short-term treated celiac disease patients who are likely still to have mucosal IgA deposits present. In addition to providing an explanation for the discrepancies in previous publications, the present study also enables further validation of the organ culture method. |
format | Text |
id | pubmed-2275217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-22752172008-03-26 Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits Stenman, Satumarja M Lindfors, Katri Korponay-Szabo, Ilma R Lohi, Olli Saavalainen, Päivi Partanen, Jukka Haimila, Katri Wieser, Herbert Mäki, Markku Kaukinen, Katri BMC Immunol Research Article BACKGROUND: In celiac disease gluten, the disease-inducing toxic component in wheat, induces the secretion of autoantibodies which are targeted against transglutaminase 2 (TG2). These autoantibodies are produced in the small-intestinal mucosa, where they can be found deposited extracellularly below the epithelial basement membrane and around mucosal blood vessels. In addition, during gluten consumption these autoantibodies can also be detected in patients' serum but disappear from the circulation on a gluten-free diet. Interestingly, after adoption of a gluten-free diet the serum autoantibodies disappear from the circulation more rapidly than the small-intestinal mucosal autoantibody deposits. The toxicity of gluten and the secretion of the disease-specific autoantibodies have been widely studied in organ culture of small-intestinal biopsy samples, but results hitherto have been contradictory. Since the mucosal autoantibodies disappear slowly after a gluten-free diet, our aim was to establish whether autoantibody secretion to organ culture supernatants in treated celiac disease patient biopsies is related to the duration of the diet and further to the pre-existence of mucosal TG2-specific IgA deposits in the cultured biopsy samples. RESULTS: In the organ culture system conducted with biopsies derived from treated celiac disease patients, gliadin induced secretion of autoantibodies to culture supernatants, reduced epithelial cell height and increased the density of lamina proprial CD25+ cells. However, these changes could be demonstrated only in biopsies from short-term treated celiac disease patients, where the small-intestinal mucosal TG2-specific IgA autoantibody deposits were still present. Furthermore, in these biopsies autoantibody secretion could be stimulated fully only after a 48-hour gliadin challenge. CONCLUSION: Our results show that studies focusing on the toxic effects of gliadin in the organ culture system should be carried out with biopsy samples from short-term treated celiac disease patients who are likely still to have mucosal IgA deposits present. In addition to providing an explanation for the discrepancies in previous publications, the present study also enables further validation of the organ culture method. BioMed Central 2008-02-29 /pmc/articles/PMC2275217/ /pubmed/18312620 http://dx.doi.org/10.1186/1471-2172-9-6 Text en Copyright © 2008 Stenman et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Stenman, Satumarja M Lindfors, Katri Korponay-Szabo, Ilma R Lohi, Olli Saavalainen, Päivi Partanen, Jukka Haimila, Katri Wieser, Herbert Mäki, Markku Kaukinen, Katri Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits |
title | Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits |
title_full | Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits |
title_fullStr | Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits |
title_full_unstemmed | Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits |
title_short | Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits |
title_sort | secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific iga deposits |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275217/ https://www.ncbi.nlm.nih.gov/pubmed/18312620 http://dx.doi.org/10.1186/1471-2172-9-6 |
work_keys_str_mv | AT stenmansatumarjam secretionofceliacdiseaseautoantibodiesafterinvitrogliadinchallengeisdependentonsmallbowelmucosaltransglutaminase2specificigadeposits AT lindforskatri secretionofceliacdiseaseautoantibodiesafterinvitrogliadinchallengeisdependentonsmallbowelmucosaltransglutaminase2specificigadeposits AT korponayszaboilmar secretionofceliacdiseaseautoantibodiesafterinvitrogliadinchallengeisdependentonsmallbowelmucosaltransglutaminase2specificigadeposits AT lohiolli secretionofceliacdiseaseautoantibodiesafterinvitrogliadinchallengeisdependentonsmallbowelmucosaltransglutaminase2specificigadeposits AT saavalainenpaivi secretionofceliacdiseaseautoantibodiesafterinvitrogliadinchallengeisdependentonsmallbowelmucosaltransglutaminase2specificigadeposits AT partanenjukka secretionofceliacdiseaseautoantibodiesafterinvitrogliadinchallengeisdependentonsmallbowelmucosaltransglutaminase2specificigadeposits AT haimilakatri secretionofceliacdiseaseautoantibodiesafterinvitrogliadinchallengeisdependentonsmallbowelmucosaltransglutaminase2specificigadeposits AT wieserherbert secretionofceliacdiseaseautoantibodiesafterinvitrogliadinchallengeisdependentonsmallbowelmucosaltransglutaminase2specificigadeposits AT makimarkku secretionofceliacdiseaseautoantibodiesafterinvitrogliadinchallengeisdependentonsmallbowelmucosaltransglutaminase2specificigadeposits AT kaukinenkatri secretionofceliacdiseaseautoantibodiesafterinvitrogliadinchallengeisdependentonsmallbowelmucosaltransglutaminase2specificigadeposits |